208 related articles for article (PubMed ID: 32942303)
1. Lifetime Mortality Risk from Cancer and Circulatory Disease Predicted from the Japanese Atomic Bomb Survivor Life Span Study Data Taking Account of Dose Measurement Error.
Little MP; Pawel D; Misumi M; Hamada N; Cullings HM; Wakeford R; Ozasa K
Radiat Res; 2020 Sep; 194(3):259-276. PubMed ID: 32942303
[TBL] [Abstract][Full Text] [Related]
2. New models for evaluation of radiation-induced lifetime cancer risk and its uncertainty employed in the UNSCEAR 2006 report.
Little MP; Hoel DG; Molitor J; Boice JD; Wakeford R; Muirhead CR
Radiat Res; 2008 Jun; 169(6):660-76. PubMed ID: 18494541
[TBL] [Abstract][Full Text] [Related]
3. Projection of cancer risks from the Japanese atomic bomb survivors to the England and Wales population taking into account uncertainty in risk parameters.
Little MP; Deltour I; Richardson S
Radiat Environ Biophys; 2000 Dec; 39(4):241-52. PubMed ID: 11200968
[TBL] [Abstract][Full Text] [Related]
4. Flexible dose-response models for Japanese atomic bomb survivor data: Bayesian estimation and prediction of cancer risk.
Bennett J; Little MP; Richardson S
Radiat Environ Biophys; 2004 Dec; 43(4):233-45. PubMed ID: 15565453
[TBL] [Abstract][Full Text] [Related]
5. Solid Cancer Incidence among the Life Span Study of Atomic Bomb Survivors: 1958-2009.
Grant EJ; Brenner A; Sugiyama H; Sakata R; Sadakane A; Utada M; Cahoon EK; Milder CM; Soda M; Cullings HM; Preston DL; Mabuchi K; Ozasa K
Radiat Res; 2017 May; 187(5):513-537. PubMed ID: 28319463
[TBL] [Abstract][Full Text] [Related]
6. Cancer and non-cancer effects in Japanese atomic bomb survivors.
Little MP
J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
[TBL] [Abstract][Full Text] [Related]
7. Solid cancer incidence in atomic bomb survivors: 1958-1998.
Preston DL; Ron E; Tokuoka S; Funamoto S; Nishi N; Soda M; Mabuchi K; Kodama K
Radiat Res; 2007 Jul; 168(1):1-64. PubMed ID: 17722996
[TBL] [Abstract][Full Text] [Related]
8. Low-Dose Extrapolation Factors Implied by Mortality and Incidence Data from the Japanese Atomic Bomb Survivor Life Span Study Data.
Little MP; Hamada N
Radiat Res; 2022 Dec; 198(6):582-589. PubMed ID: 36161867
[TBL] [Abstract][Full Text] [Related]
9. Mortality among individuals exposed to atomic bomb radiation in utero: 1950-2012.
Sugiyama H; Misumi M; Sakata R; Brenner AV; Utada M; Ozasa K
Eur J Epidemiol; 2021 Apr; 36(4):415-428. PubMed ID: 33492551
[TBL] [Abstract][Full Text] [Related]
10. Assessing the impact of neutron relative biological effectiveness on all solid cancer mortality risks in the Japanese atomic bomb survivors.
Hafner L; Walsh L; Rühm W
Int J Radiat Biol; 2024; 100(1):61-71. PubMed ID: 37772764
[TBL] [Abstract][Full Text] [Related]
11. Derivation of low-dose extrapolation factors from analysis of curvature in the cancer incidence dose response in Japanese atomic bomb survivors.
Little MP; Muirhead CR
Int J Radiat Biol; 2000 Jul; 76(7):939-53. PubMed ID: 10923618
[TBL] [Abstract][Full Text] [Related]
12. Cancer mortality risk among workers at the Mayak nuclear complex.
Shilnikova NS; Preston DL; Ron E; Gilbert ES; Vassilenko EK; Romanov SA; Kuznetsova IS; Sokolnikov ME; Okatenko PV; Kreslov VV; Koshurnikova NA
Radiat Res; 2003 Jun; 159(6):787-98. PubMed ID: 12751962
[TBL] [Abstract][Full Text] [Related]
13. Comparison of All Solid Cancer Mortality and Incidence Dose-Response in the Life Span Study of Atomic Bomb Survivors, 1958-2009.
Brenner AV; Preston DL; Sakata R; Cologne J; Sugiyama H; Utada M; Cahoon EK; Grant E; Mabuchi K; Ozasa K
Radiat Res; 2022 May; 197(5):491-508. PubMed ID: 35213725
[TBL] [Abstract][Full Text] [Related]
14. A framework for estimating radiation-related cancer risks in Japan from the 2011 Fukushima nuclear accident.
Walsh L; Zhang W; Shore RE; Auvinen A; Laurier D; Wakeford R; Jacob P; Gent N; Anspaugh LR; Schüz J; Kesminiene A; van Deventer E; Tritscher A; del Rosarion Pérez M
Radiat Res; 2014 Nov; 182(5):556-72. PubMed ID: 25251702
[TBL] [Abstract][Full Text] [Related]
15. Are cancer risks associated with exposures to ionising radiation from internal emitters greater than those in the Japanese A-bomb survivors?
Little MP; Hall P; Charles MW
Radiat Environ Biophys; 2007 Nov; 46(4):299-310. PubMed ID: 17639450
[TBL] [Abstract][Full Text] [Related]
16. Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990.
Pierce DA; Shimizu Y; Preston DL; Vaeth M; Mabuchi K
Radiat Res; 1996 Jul; 146(1):1-27. PubMed ID: 8677290
[TBL] [Abstract][Full Text] [Related]
17. Studies of the mortality of atomic bomb survivors, Report 14, 1950-2003: an overview of cancer and noncancer diseases.
Ozasa K; Shimizu Y; Suyama A; Kasagi F; Soda M; Grant EJ; Sakata R; Sugiyama H; Kodama K
Radiat Res; 2012 Mar; 177(3):229-43. PubMed ID: 22171960
[TBL] [Abstract][Full Text] [Related]
18. Risk of cancer associated with low-dose radiation exposure: comparison of results between the INWORKS nuclear workers study and the A-bomb survivors study.
Leuraud K; Richardson DB; Cardis E; Daniels RD; Gillies M; Haylock R; Moissonnier M; Schubauer-Berigan MK; Thierry-Chef I; Kesminiene A; Laurier D
Radiat Environ Biophys; 2021 Mar; 60(1):23-39. PubMed ID: 33479781
[TBL] [Abstract][Full Text] [Related]
19. Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997.
Preston DL; Shimizu Y; Pierce DA; Suyama A; Mabuchi K
Radiat Res; 2003 Oct; 160(4):381-407. PubMed ID: 12968934
[TBL] [Abstract][Full Text] [Related]
20. Radiation-Related Risk of Cancers of the Upper Digestive Tract among Japanese Atomic Bomb Survivors.
Sakata R; Preston DL; Brenner AV; Sugiyama H; Grant EJ; Rajaraman P; Sadakane A; Utada M; French B; Cahoon EK; Mabuchi K; Ozasa K
Radiat Res; 2019 Sep; 192(3):331-344. PubMed ID: 31356146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]